Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice.
BH4 (tetrahydrobiopterin) supplementation improves endothelial function in models of vascular disease by maintaining eNOS (endothelial nitric oxide synthase) coupling and NO (nitric oxide) bioavailability. However, the cellular mechanisms through which enhanced endothelial function leads to reduced...
Main Authors: | Schmidt, T, McNeill, E, Douglas, G, Crabtree, M, Hale, AB, Khoo, J, O'Neill, C, Cheng, A, Channon, K, Alp, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Low-dose Tetrahydrobiopterin Supplementation Reduces Atherosclerosis Progression in Apolipoprotein E-Knockout Mice via Effects on Vascular T cell Infiltration
by: Schmidt, T, et al.
Published: (2009) -
Long-term oral tetrahydrobiopterin supplementation reduces atherosclerosis in apolipoprotein e knockout mice
by: Schmidt, T, et al.
Published: (2008) -
Long-term oral tetrahydrobiopterin supplementation reduces atherosclerosis in apolipoprotein E-KO mice
by: Schmidt, T, et al.
Published: (2008) -
Conditional knockout of GCH1 in leukocytes and endothelial cells: A novel model to study tetrahydrobiopterin-dependent NOS functions in vivo
by: McNeill, E, et al.
Published: (2012) -
A key role for tetrahydrobiopterin-dependent endothelial NOS regulation in vascular resistance arteries: studies in endothelial cell tetrahydrobiopterin-deficient mice
by: Chuaiphichai, S, et al.
Published: (2017)